Immix Biopharma, Inc.IMMXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank67
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Percentile
P67
Within normal range
vs 2Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$524665.00-48.4%
2024$1.02M+77.9%
2023$572006.00+115191.8%
2022$-497.00+100.0%
2021$-23.03M-3303.9%
2020$-676464.00-516.3%
2019$-109760.00-